Pharmaceutical compositions
US6218380A · kind A · utility
17Cited by
4References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 1991 |
| Grant date | Apr 17, 2001 |
| Priority date | — |
| Expiry date | Aug 15, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A new antibacterially active agent has been isolated from Streptomyces clavuligerus. This new compound which is designated clavulanic acid has the formula (I): ##STR1## In addition to being a broad spectrum antibiotic of medium potency, clavulanic acid and its salts and esters have the ability to enhance the effectiveness of .beta. lactam antibiotics against many .beta.-lactamase producing bacteria.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.